In vitro characterization of T lymphocytes from human atherosclerotic lesions.
ID
Source
Brief title
Condition
- Coronary artery disorders
- Hepatobiliary neoplasms malignant and unspecified
- Arteriosclerosis, stenosis, vascular insufficiency and necrosis
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Proliferation responses against different antigens of atherosclerotic plaque
derived T lymphocytes.
Secondary outcome
N.A.
Background summary
Atherosclerotic lesions are characterized by the presence of an inflammatory
infiltrate, predominantly macrophages and T lymphocytes. Several lines of
evidence have shown that local activation of T lymphocytes contributes to
atherosclerotic plaque inflammation and the onset of acute cardiovascular
complications. At present it is not clear which antigens are responsible for
the activation of T lymphocytes in human atherosclerotic tissue, but antigens
that have been suggested to play a role include lipoproteins and antigens from
microbial origin. The aim of the present study is a functional characterization
(including the antigen specificity) of T cells from unstable human
atherosclerotic lesions.
Study objective
In vitro characterization of T lymphocytes from human atherosclerotic lesions.
Study design
Isolation of T lymphocytes from human atherosclerotic tissue, and further in
vitro characterization. Because we want to increase the amount of tissue with
which we can perform experiments, tissue will be collected at two diferent
locations, the Slotervaart hospital and the AMC. Studies that will be perfomed
with these specimens are similar to those that have already been published:
- de Boer et al, Cardiovasc Res. 2000 48: 402-8.
- de Boer et al, Atherosclerosis. 2006 184:322-9.
Study burden and risks
NA
Meibergdreef 9
1105 AZ Amsterdam
NL
Meibergdreef 9
1105 AZ Amsterdam
NL
Listed location countries
Age
Inclusion criteria
Obstructive carotid artery disease (TIA), claudicatio intermittens
Exclusion criteria
Immunedeficiency, immunosuppressive therapy, sepsis
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL16045.018.07 |